FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE – Trademark Portfolio

Entity Type: 11

FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SOMASK. The owner is based in FOSHAN.

NO. 109, LANE 2, LIUHUAYUAN STREET, JIAOTANG ROAD, RONGGUI STREET, SHUNDE DISTRICT

FOSHAN 528000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SOMASK
SOMASK
Registered 2020

Trademark Classifications

FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE have?

FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE file in?

FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE's most well-known trademarks?

FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE's registered trademark portfolio includes well-known marks such as SOMASK. These are among 1 currently registered trademark in the portfolio.

What is FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE's trademark registration success rate?

FOSHAN SHUNDE NINGMENGHUAN DEPARTMENT STORE has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.